SEC secures admission from Orthofix after repeat FCPA violations

In a rare move, the US Securities and Exchange Commission obtained an admission of wrongdoing from Orthofix, a medical device company, in a foreign bribery settlement that did not involve parallel criminal charges.

Get unlimited access to all Global Investigations Review content